Table 2.
COVID-19 vaccination preferences among the unvaccinated (N = 335), during a pause in Johnson & Johnson (J&J) vaccine, April 2021.
| Would get J&J vaccine right away | Willing to wait 1 month for Pfizer vaccine | Willing to wait 3 months for Pfizer vaccine | Does not want any vaccine |
P-valuea | |
|---|---|---|---|---|---|
| Overall | 60 (18 %) | 16 (5 %) | 80 (25 %) | 179 (52 %) | |
| Gender | 0.0002 | ||||
| Female | 21 (11 %) | 10 (5 %) | 43 (23 %) | 123 (61 %) | |
| Male | 39 (28 %) | 6 (4 %) | 37 (27 %) | 56 (40 %) | |
| Age | 0.0207 | ||||
| 18–39 | 41 (22 %) | 9 (5 %) | 48 (27 %) | 86 (46 %) | |
| 40–64 | 13 (12 %) | 6 (5 %) | 30 (26 %) | 66 (57 %) | |
| ≥65 | 6 (16 %) | 1 (3 %) | 2 (5 %) | 27 (76 %) | |
| Race/ethnicity | 0.8249 | ||||
| Hispanic | 8 (25 %) | 2 (8 %) | 6 (20 %) | 15 (47 %) | |
| NH Black | 10 (24 %) | 2 (5 %) | 8 (22 %) | 21 (49 %) | |
| NH white | 42 (18 %) | 11 (4 %) | 54 (23 %) | 133 (55 %) | |
| Other | 0 | 1 (3 %) | 12 (56 %) | 10 (41 %) | |
| Education | 0.4353 | ||||
| High school or below | 20 (19 %) | 5 (6 %) | 20 (21 %) | 55 (54 %) | |
| College and above | 40 (18 %) | 11 (4 %) | 60 (26 %) | 124 (52 %) | |
| Vaccine hesitancy | <0.0001 | ||||
| Hesitant | 29 (11 %) | 11 (5 %) | 44 (19 %) | 163 (65 %) | |
| Not hesitant | 29 (35 %) | 5 (5 %) | 35 (42 %) | 15 (17 %) | |
| Heard about Blood clots | 0.0010 | ||||
| Yes | 22 (12 %) | 9 (4 %) | 42 (23 %) | 121 (61 %) | |
| No | 38 (27 %) | 7 (5 %) | 38 (27 %) | 58 (41 %) |
Notes: NH, non-Hispanic.
a
Rao-Scott chi-square test, except for race/ethnicity, which is a Fisher’s exact test.